跳至主要内容
临床试验/JPRN-UMIN000015352
JPRN-UMIN000015352已完成未知

A randamized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy of oral administration of probiotic LKM512 and arginine on function of vascular endothelium in individuals with pre-metabolic syndrome - Effects of probiotic LKM512 and arginine on function of vascular endothelium

Kyodo Milk Industry Co. Ltd.0 个研究点目标入组 40 人开始时间: 2014年10月7日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Outpatients whose BMl is more than 25.0 2. Subjects who take a medicine for dyslipidemia treatment 3. Serious subjects who have complications with cardiac disease, hepatic disease,and/or renal disease 4. Subjects who had serious gastrointestinal disease in the past 5. Subjects who take hypotensive medicines 6. Subjects who have serious constipation 7. Subjects who was enrolled in other trails within one month 8. Inappropriate cases evaluated by doctors

研究者

相似试验

已完成
不适用
A randamized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy of yogurt containing probiotic LKM512 and arginine on function of vascular endothelium and intestinal environment
JPRN-UMIN000023857Kyodo Milk Industry Co. Ltd.40
招募中
不适用
A randamized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of oral administration of probiotic LKM512 in individuals with pre-arteriosclerosis
JPRN-UMIN000010813Kyodo Milk Industry Co. Ltd.30
已完成
2 期
A Randomized, double blind, placebo-controlled, parallel-group study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple oral doses of CNP520 in healthy elderly subjectsAlzheimer diseasealzheimer diseasedementia
NL-OMON42784ovartis30
进行中(未招募)
1 期
An international study assessing the efficacy of a new drug (S 066913) in paroxysmal atrial fibrillatioMedDRA version: 18.0Level: LLTClassification code 10034039Term: Paroxysmal atrial fibrillationSystem Organ Class: 100000004849Paroxysmal Atrial Fibrillation
EUCTR2014-002333-63-CZInstitut de Recherches Internationales Servier160
已完成
2 期
A randomized, double blind, placebo-controlled, parallel, international multicenter study assessing the efficacy of S066913 in patients with paroxysmal atrial fibrillation. Double-blind, International study AssessinG efficacy of S066913 in paRoxysmal Atrial Fibrillation -IKur inhibitor (DIAGRAF - IKUR)paroxysmal atrial fibrillation
NL-OMON41862Institut de Recherches Internationales Servier I.R.I.S34